Abivax SA American Depositary Shares (ABVX) is a publicly traded Healthcare sector company. As of July 7, 2026, ABVX trades at $145.45 with a market cap of $11.54B and a P/E ratio of 0.00. ABVX moved -0.40% today. Year to date, ABVX is +4.08%; over the trailing twelve months it is +1708.92%. Its 52-week range spans $4.77 to $148.83. Analyst consensus is strong buy with an average price target of $154.25. Rallies surfaces ABVX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for ABVX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $145.45 |
| Market Cap | $11.54B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $148.83 |
| 52-Week Low | $4.77 |
| Volume | 1.42M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
12 analysts cover ABVX: 0 strong buy, 11 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $154.25.